Sydney Brehany, MD

NPI 1821529363ActiveIndividual· Internal Medicine, Medical Oncology· Des Moines, IA

Internal Medicine, Medical Oncology (MD) in Des Moines, Iowa, trained at Creighton University School of Medicine (class of 2017). In 2024 Medicare paid $1,256,848 for 314 patients, and Part D covered 296 of their prescriptions, 87% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $85.84 in all, mostly education.

Overview

NPI	1821529363
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Mar 26, 2017
Last updated in NPPES	Nov 17, 2025
Certified by provider	Nov 17, 2025

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Medical Oncology Primary	207RX0202X	MD-54017	IA
Internal Medicine, Hematology	207RH0000X	MD-54017	IA
Internal Medicine	207R00000X	MD-54017	IA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hospitalist (CO); Practitioner - Medical Oncology (IA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	314
Services billed	56,696 across 132 procedure codes
Paid by Medicare	$1,256,848

Part D prescriptions in 2024

Prescriptions (claims)	296 · 569 30-day fills
Patients	84
Total drug cost	$386,052
Generic share	87% of claims

Medicare sources and data years

Education and affiliations

Medical school	Creighton University School of Medicine
Graduation year	2017
Medicare specialty	Medical Oncology
Secondary specialties	Hematology
Telehealth	Offers telehealth